多巴胺受体表达预测了卡贝戈林对持续性索马托罗普腺瘤的反应
Remya Rajan R1, Hesarghatta Shyamasunder1, Geeta Chacko2
1Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India.
Pituitary
|July 23, 2025
概括
在生长激素分泌的垂体瘤中,多巴胺受体亚型2 (D2R) 表达预测了卡伯戈林治疗的巨缓解. 较高的D2RmRNA水平表明治疗成功的可能性更高.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 卡伯戈林对于在资源有限的环境中管理积症至关重要,特别是在手术后的持久性疾病中.
- 治疗反应可能与体内瘤中的特定受体表达特征相关.
研究的目的:
- 通过免疫组织化学 (IHC) 和定量聚合酶链反应 (qPCR) 来研究体内瘤中多巴胺受体亚型2 (D2R) 和体内静止素受体亚型2和5 (SSTR2和SSTR5) 的表达.
- 评估卡伯戈林治疗患者的D2R表达密度和缓解率之间的关系.
主要方法:
- 分析了30个体育瘤样本,这些样本来自手术后患有持续性壮症的患者,这些患者接受了卡伯戈林治疗.
- 在存档的垂体腺瘤样本上进行免疫染和qPCR.
- 从电子医疗记录中收集的临床,生化和放射学数据.
主要成果:
- D2R是表达最强的受体,其次是SSTR2和SSTR5.
- 23%的患者在卡伯戈林治疗后实现了缓解 (IGF-I或GH水平正常化).
- 较高的基线D2RmRNA表达显著预测了缓解,D2R ΔΔ CT为19.2表示19倍的更高表达和预测缓解,敏感度为71%和特异性为74%.
结论:
- 多巴胺受体亚型2 (D2R) 分析生长激素分泌 pituitary 瘤是一个有价值的工具.
- 3个月后手术后的IGF-1水平也可以帮助预测对卡伯戈林治疗的反应.
相关概念视频
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
622
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
622
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
446
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
446
Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
Parkinson's Disease: Treatment
381
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
381
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
Spare Receptors
3.8K
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
3.8K


